News
The experimental hydrogel-based remedy has successfully passed primary clinical trials
11.01.2020

American startup Ventrix has developed and successfully tested VentriGel hydrogel-based remedy for repairing heart damage.

Scientists from Australia have developed a vaccine that can protect against tuberculosis throughout life
08.01.2020

The vaccine is intended for inhalation and works in the lungs causing the body to produce the immune response directly in the lung cells. This approach should allow to use the vaccine in all groups of patients, in contrast to BCG, which has several limitations.

GOOGLE is testing artificial intelligence to diagnose skin diseases
08.01.2020

Researchers from Google have reported that their AI can detect and identify 26 skin conditions (as much as a certified American dermatologist determines).

Johns Hopkins University raised $17 million to study psychedelics
08.01.2020

The university has opened a Centre for the study of psychedelics as medications for the treatment of neurological diseases. It was sponsored by Steven and Alexandra Cohen Foundation and four benefactors who raised about $ 17 million.

Cell therapy has worked for multiple sclerosis
26.12.2019

"Innovative" and "provocative" therapies with mesenchymal stem cells in case of progressive multiple sclerosis have shown good results.

The world's first complete digital clinical trial has been carried out.
23.12.2019

Scientists from Stanford University School of Medicine have reported the success of the world's first complete digital randomized clinical trial. A document showing the results of the work was published in The Lancet Digital Health.

Alcoholism will be treated with
21.12.2019

Swedish medicines manufacturer Orexo, best known for its medicines for opioid addiction, has licensed an innovative digital therapy for alcohol addiction.

A unique diagnostic test has been developed for cardiologists
28.11.2019

A blood test for detection of inflammation can foresee an individual risk of developing heart and vascular diseases or early death 40 years before real problems arise. The authors of the development are the scientists of Sloan Kettering Cancer Center.

Bacterial infection is the best alternative to dengue vaccine
16.12.2019

Scientists have found that Wolbachia bacterium used to fight mosquitoes can be a very cheap and effective way to fight dengue virus.